Several countries are in the process of switching to high-risk human papillomavirus (hrHPV)
testing for cervical cancer screening. Given the multitude of available tests, validated assays …

Human papillomavirus (HPV) has been identified as a necessary factor in the development
of pre-invasive and invasive cancers of the lower genital tract, of which cervical cancer is the …

High-risk human papillomaviruses (HPVs) cause essentially all cervical cancers, most anal
and oropharyngeal cancers, and some vaginal, vulvar, and penile cancers. Improved …

Methods The Canadian Task Force on Preventive Health Care is an independent panel of
clinicians and methodologists that makes recommendations about clinical manoeuvres …

Background: Several new assays have been developed for high-risk HPV testing of cervical
samples; we compare six HPV tests in a screening population. Methods: Residual material …

Commercial molecular tests for human papillomaviruses (HPV) are invaluable diagnostic
tools in cervical carcinoma screening and management of women with cervical …

Background Atypical squamous cells of undetermined significance (ASCUS) and low‐grade
squamous intra‐epithelial lesions (LSIL) are minor lesions of the cervical epithelium …

The advent of US Food and Drug Administration (FDA)-approved molecular testing for
human papillomavirus (HPV) has resulted in a dramatic shift from cytological testing alone to …

Cytology-based nation-wide cervical screening has led to a substantial reduction of the
incidence of cervical cancer in western countries. However, the sensitivity of cytology for the …

This comprehensive review compiles published data from 62 original articles comparing
different HPV tests and one meta-analysis on the clinical performance of the Aptima HR HPV …